In contrast, according to the only study so far that reported on the USP44 activity in prostate cancer, the expression of USP44 appeared to promote tumor growth through the expression of the EZH2 in prostate cancer cell lines, a histone-modifying enzyme which modulates the expression of genes involved in cell cycle and DNA repair. Here, EZH2 is linked to Familial prostate cancer.